Aqneursa (levacetylleucine)

Ataxia-telangiectasia

Also known as IB1001

Manufacturer: IntraBio
Regulatory submission: sNDA submitted March 2026 and approved September 2026
Launch: Commercially available at approval in September 2026
Last updated: October 2, 2026

Section

Product information and disease description Place of product in therapy Disease description

Epidemiology

14 evidence topics · 17 sources